Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback